Business · 04/11/20261 min read
Opinion/decision on a PIP: Uplizna, inebilizumab, type of decision: PM: decision on the application for modification of an agreed PIP, area of treatment: Musculoskeletal and connective tissue disorders, number of PIP: EMA/PE/0000252649
Summary
Opinion/decision on a PIP: Uplizna, inebilizumab, type of decision: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective...